Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss

Clinical trial NCT07627971 · RECRUITING

Trial details

NCT number: NCT07627971
Sponsor: Skylark Bio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

GJB2-mediated Hearing Loss GJB2 Gene Mutation DFNB1A

Start date: 2026-05-28
Primary completion: 2027-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.